newsfilter
← Latest News
PR Newswire·

DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants

CUPERTINO, Calif., Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ